GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ectin Research AB (XSAT:ECTIN B) » Definitions » Quick Ratio

Ectin Research AB (XSAT:ECTIN B) Quick Ratio : 2.47 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ectin Research AB Quick Ratio?

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Ectin Research AB's quick ratio for the quarter that ended in Mar. 2024 was 2.47.

Ectin Research AB has a quick ratio of 2.47. It generally indicates good short-term financial strength.

The historical rank and industry rank for Ectin Research AB's Quick Ratio or its related term are showing as below:

XSAT:ECTIN B' s Quick Ratio Range Over the Past 10 Years
Min: 1.06   Med: 9.13   Max: 41.38
Current: 2.47

During the past 4 years, Ectin Research AB's highest Quick Ratio was 41.38. The lowest was 1.06. And the median was 9.13.

XSAT:ECTIN B's Quick Ratio is ranked worse than
60.1% of 1539 companies
in the Biotechnology industry
Industry Median: 3.58 vs XSAT:ECTIN B: 2.47

Ectin Research AB Quick Ratio Historical Data

The historical data trend for Ectin Research AB's Quick Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ectin Research AB Quick Ratio Chart

Ectin Research AB Annual Data
Trend Aug19 Aug20 Dec22 Dec23
Quick Ratio
40.59 9.13 9.24 4.28

Ectin Research AB Quarterly Data
Aug19 Aug20 Mar21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Quick Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.51 9.91 6.37 4.28 2.47

Competitive Comparison of Ectin Research AB's Quick Ratio

For the Biotechnology subindustry, Ectin Research AB's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ectin Research AB's Quick Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ectin Research AB's Quick Ratio distribution charts can be found below:

* The bar in red indicates where Ectin Research AB's Quick Ratio falls into.



Ectin Research AB Quick Ratio Calculation

The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.

Ectin Research AB's Quick Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Quick Ratio (A: Dec. 2023 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(6.417-0)/1.499
=4.28

Ectin Research AB's Quick Ratio for the quarter that ended in Mar. 2024 is calculated as

Quick Ratio (Q: Mar. 2024 )=(Total Current Assets-Total Inventories)/Total Current Liabilities
=(4.408-0)/1.788
=2.47

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ectin Research AB  (XSAT:ECTIN B) Quick Ratio Explanation

The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.

In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.

The higher the quick ratio, the better the company's liquidity position.


Ectin Research AB Quick Ratio Related Terms

Thank you for viewing the detailed overview of Ectin Research AB's Quick Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Ectin Research AB (XSAT:ECTIN B) Business Description

Traded in Other Exchanges
N/A
Address
Pepparedsleden 1, Molndal, SWE, 431 83
Ectin Research AB is a pharmaceutical company developing a novel treatment that eliminates cancer tumors. Its drug candidate MFA-370 engages in the treatment of metastatic bladder cancer, and has also shown potential in other cancers such as breast, colorectal and prostate cancer cells.

Ectin Research AB (XSAT:ECTIN B) Headlines

No Headlines